Nutritional treatment of chronic liver failure

Hepatology Research

Volumn 38, Issue SUPPL. 1, 2008, Pages

  Bianchi, Giampaolo ^a   Marzocchi, Rebecca ^b   Lorusso, Caterina ^b   Ridolfi, Valentina ^b   Marchesini, Giulio ^b,c  

^a Unit of Internal Medicine   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Branched chain amino acids; Cirrhosis; Encephalopathy; Liver failure; Micronutrients; Zinc

Indexed keywords

BRANCHED CHAIN AMINO ACID; FAT; GLUCOSE; ISOLEUCINE; LEUCINE; MINERAL; PROTEIN DERIVATIVE; SODIUM; TRACE ELEMENT; VALINE; VEGETABLE PROTEIN; VITAMIN; ZINC;

BEDTIME DOSAGE; CHRONIC DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIET THERAPY; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EVENING DOSAGE; GRAFT SURVIVAL; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MORNING DOSAGE; NAUSEA; NUTRIENT; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CALORIE MALNUTRITION; QUALITY OF LIFE; SODIUM DEFICIENCY; ZINC DEFICIENCY;

EID: 58049125468     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00433.x     Document Type: Conference Paper

References (82)

1. Changani KK, Jalan R, Cox IJ etal. Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy. Gut 2001; 49: 557-64.
2. Campillo B, Chapelain C, Bonnet JC et al. Hormonal and metabolic changes during exercise in cirrhotic patients. Metabolism 1990; 39: 18-24.
3. Nielsen MF, Caumo A, Aagaard NK et al. Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: assessment during physiological glucose and insulin concentrations. Am J Physiol Gastrointest Liver Physiol 2005; 288: G1135-43.
4. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994; 20: 119-25.
5. Swart GR, van den Berg JWO, Wattinema DL, Rietvald T, van Vuure JK, Frenkel M. Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies. Clin Sci 1988; 75: 101-7.
6. Kondrup J, Nielsen K, Juul A. Effect of long-term refeeding on protein metabolism in patients with cirrhosis of the liver. Br J Nutr 1997; 77: 197-212.
7. Rosen HM, Yoshimura N, Hodgmann JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology 1977; 72: 483-7.
8. Felig P, Wahren J, Sherwin R, Palaiologos G. Amino acid and protein metabolism in diabetes mellitus. Arch Intern Med 1977; 137: 507-13.
9. Soeters PB, Fischer JE. Insulin, glucagon, amino acid imbalance, and hepatic encephalopathy. Lancet 1976; 2: 880-2.
10. McCullough AJ, Mullen KD, Kalhan SC. Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion. Hepatology 1998; 28: 1357-64.
11. Zoli M, Marchesini G, Dondi C, Bianchi GP, Pisi E. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting. Clin Sci (Lond) 1982; 62: 683-6.
12. Bugianesi E, Tangerman A, Ronchi M, Bianchi G, Marchesini G. Transamination of methionine after loading in patients with cirrhosis. J Hepatol 1996; 24: 95-100.
13. Bianchi G, Brizi M, Rossi B, Ronchi M, Grossi G, Marchesini G. Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis. Metabolism 2000; 49: 1434-9.
14. Tajika M, Kato M, Mohri H et al. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 2002; 18: 229-34.
15. Dolz C, Raurich JM, Ibanez J, Obrador A, Marse P, Gaya J. Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology 1991; 100: 738-44.
16. Nielsen K, Kondrup J, Martinsen L, Stilling B, Wikman B. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis. Br J Nutr 1993; 69: 665-79.
17. Muller MJ, Bottcher J, Selberg O et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 1999; 69: 1194-201.
18. Riggio O, Angeloni S, Ciuffa L et al. Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis. Clin Nutr 2003; 22: 553-9.
19. Pikul J, Sharpe MD, Lowndes R, Ghent CN. Degree of preoperative malnutrition is predictive of postoperative morbidity and mortality in liver transplant recipients. Transplantation 1994; 57: 469-72.
20. Merli M, Riggio O, Dally L, Italiana Nutrizione P, C. Does malnutrition affect survival in cirrhosis? Hepatology 1996; 23: 1041-6.
21. Stephenson GR, Moretti EW, El-Moalem H, Clavien PA, Tuttle-Newhall JE. Malnutrition in liver transplant patients: Preoperative subjective global assessment is predictive of outcome after liver transplantation. Transplantation 2001; 72: 666-70.
22. Alberino F, Gatta A, Amodio P et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001; 17: 445-50.
23. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002; 26: SA1-138.
24. Muller MJ. Malnutrition in cirrhosis. J Hepatol 1995; 23 (Suppl 1): 31-5.
25. Madden AM, Morgan MY. A comparison of skinfold anthropometry and bioelectrical impedance analysis for measuring percentage body fat in patients with cirrhosis. J Hepatol 1994; 21: 878-83.
26. McCullough AJ, Mullen KD, Kalhan SC. Measurements of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology 1991; 14: 1102-11.
27. Muller MJ. Malnutrition and hypermetabolism in patients with liver cirrhosis. Am J Clin Nutr 2007; 85: 1167-8.
28. Hasse J, Strong S, Gorman MA, Liepa G. Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates. Nutrition 1993; 9: 339-43.
29. Detsky AS, Baker JP, Mendelson RA, Wolman SL, Wesson DE, Jeejeebhoy KN. Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: Methodology and comparisons. JPEN J Parenter Enteral Nutr 1984; 8: 153-9.
30. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981; 34: 2540-5.
31. Morgan MY, Madden AM, Soulsby CT, Morris RW. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology 2006; 44: 823-35.
32. Kondrup J, Johansen N, Plum LM et al. Incidence of nutritional risk and causes of inadequate nutritional care in hospitals. Clin Nutr 2002; 21: 461-8.
33. Fischer JE. Branched-chain amino acid solutions in patients with liver failure: An early example of nutritional pharmacology. J Parent Enter Nutr 1990; 14 (Suppl): 249 -56.
34. Plauth M, Cabre E, Riggio O et al. ESPEN guidelines on enteral nutrition: Liver disease. Clin Nutr 2006; 25: 285-94.
35. Nompleggi DJ, Bonkovsky HL. Nutritional supplementation in chronic liver disease: An analytical review. Hepatology 1994; 19: 518-33.
36. Cordoba J, Lopez-Hellin J, Planas M et al. Normal protein diet for episodic hepatic encephalopathy: Results of a randomized study. J Hepatol 2004; 41: 38-43.
37. Plauth M, Merli M, Kondrup J et al. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997; 16: 43-55.
38. Tozun N. Influence of the metabolic complications of liver cirrhosis on dietary intake. Med Sci Monit 2000; 6: 1223-6.
39. Bianchi GP, Marchesini G, Fabbri A et al. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. J Intern Med 1993; 233: 385-92.
40. Rayes N, Seehofer D, Theruvath T et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation -a randomized, double-blind trial. Am J Transplant 2005; 5: 125-30.
41. Owen OE, Trapp VE, Reichard GA Jr et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983; 72: 1821-32.
42. Chang WK, Chao YC, Tang HS, Lang HF, Hsu CT. Effects of extra-carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. JPEN J Parenter Enteral Nutr 1997; 21: 96-9.
43. Miwa Y, Shiraki M, Kato M et al. Improvement of fuel metabolism by nocturnal energy supplementation in patients with liver cirrhosis. Hepatol Res 2000; 18: 184-9.
44. Swart GR, Zillikens MC, van Vuure JK, van den Berg JW. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. Br Med J 1989; 299: 1202-3.
45. Verboeket-van de Venne WP, Westerterp KR, van Hoek B, Swart GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: Effects of the pattern of food intake. Gut 1995; 36: 110-16.
46. Felig P, Wahren J. Protein turnover and amino acid metabolism in the regulation of gluconeogenesis. Fed Proc 1974; 33: 1092-7.
47. Marchesini G, Zoli M, Dondi C, Bianchi GP, Cirulli M, Pisi E. Anticatabolic effects of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology 1982; 2: 420-5.
48. Tomiya T, Inoue Y, Yanase M et al. Treatment with leucine stimulates the production of hepatocyte growth factor in vivo. Biochem Biophys Res Commun 2004; 322: 772-7.
49. Bianchi G, Marzocchi R, Agostini F, Marchesini G. Update on branched-chain amino acid supplementation in liver diseases. Curr Opin Gastroenterol 2005; 21: 197-200.
50. Bianchi G, Marzocchi R, Agostini F, Marchesini G. Update on nutritional supplementation with branched-chain amino acids. Curr Opin Clin Nutr Metab Care 2005; 8: 83-7.
51. Donaghy A. Issues of malnutrition and bone disease in patients with cirrhosis. J Gastroenterol Hepatol 2002; 17: 462-6.
52. Marchesini G, Bianchi G, Merli M et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: A double-blind, randomized trial. Gastroenterology 2003; 124: 1792-801.
53. Muto Y, Sato S, Watanabe A et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005; 3: 705-13.
54. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy (Cochrane review). In: The Cochrane Library, Issue 2. Chichester, UK: John Wiley & Sons, Ltd, 2004.
55. Fukushima H, Miwa Y, Ida E et al. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: Comparison with daytime administration. JPEN J Parenter Enteral Nutr 2003; 27: 315-22.
56. Tsuchiya M, Sakaida I, Okamoto M, Okita K. The effect of a late evening snack in patients with liver cirrhosis. Hepatol Res 2005; 31: 95-103.
57. Nakaya Y, Okita K, Suzuki K et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007; 23: 113-20.
58. Fitzgerald K, Mikalunas V, Rubin H, McCarthey R, Vanagunas A, Craig RM. Hypermanganesemia in patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 1999; 23: 333-6.
59. Ukleja A, Scolapio JS, McConnell JP et al. Nutritional assessment of serum and hepatic vitamin A levels in patients with cirrhosis. JPEN J Parenter Enteral Nutr 2002; 26: 184-8.
60. Kanematsu T, Kawano T, Sugimachi K. Blood concentrations of thirteen vitamins in cirrhotic patients. Nutrition 1989; 5: 179-82.
61. Smith JC Jr. The vitamin A-zinc connection: A review. Ann N Y Acad Sci 1980; 355: 62-75.
62. Bode JC, Hanisch P, Henning H, Koenig W, Richter FW, Bode C. Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology 1988; 8: 1605-9.
63. Goode HF, Kelleher J, Walker BE. Relation between zinc status and hepatic functional reserve in patients with liver disease. Gut 1990; 31: 694-7.
64. Capocaccia L, Merli M, Piat C, Servi R, Zullo A, Riggio O. Zinc and other trace elements in liver cirrhosis. Ital J Gastroenterol 1991; 23: 386-91.
65. Gohshi K, Fujiyama S, Shibata J, Sato T, Higashi A, Matsuda I. Zinc absorption and its correlation with results of oral zinc tolerance testing in nonalcoholic liver cirrhosis; kinetic study. Hepatogastroenterology 1995; 42: 487-91.
66. Keeling PW, Ruse W, Bull J, Hannigan B, Thompson RP. Direct measurement of the hepatointestinal extraction of zinc in cirrhosis and hepatitis. Clin Sci (Lond) 1981; 61: 441-4.
67. Rocchi E, Borella P, Borghi A et al. Zinc and magnesium in liver cirrhosis. Eur J Clin Invest 1994; 24: 149-55.
68. Prasad AS. The role of zinc in gastrointestinal and liver disease. Clin Gastroenterol 1983; 12: 713-41.
69. Chandra RK, McBean LD. Zinc and immunity. Nutrition 1994; 10: 79-80.
70. Prasad AS. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis 2000; 182 (Suppl 1): S62-8.
71. Essatara MB, Levine AS, Morley JE, McClain CJ. Zinc deficiency and anorexia in rats: Normal feeding patterns and stress induced feeding. Physiol Behav 1984; 32: 469-74.
72. Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996; 23: 1084-92.
73. Grungreiff K, Abicht K, Kluge M et al. Clinical studies on zinc in chronic liver diseases. Z Gastroenterol 1988; 26: 409-15.
74. Morrison SA, Russell RM, Carney EA, Oaks EV. Zinc deficiency: A cause of abnormal dark adaptation in cirrhotics. Am J Clin Nutr 1978; 31: 276-81.
75. Riggio O, Ariosto F, Merli M et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci 1991; 36: 1204-8.
76. Yang SS, Lai YC, Chiang TR, Chen DF, Chen DS. Role of zinc in subclinical hepatic encephalopathy: Comparison with somatosensory-evoked potentials. J Gastroenterol Hepatol 2004; 19: 375-9.
77. Weismann K, Christensen E, Dreyer V. Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial. Acta Med Scand 1979; 205: 361-6.
78. Marchesini G, Bugianesi E, Ronchi M, Flamia R, Thomaseth K, Pacini G. Zinc supplementation improves glucose disposal in patients with cirrhosis. Metabolism 1998; 47: 792-8.
79. MacDonald RS. The role of zinc in growth and cell proliferation. J Nutr 2000; 130: 1500S-8S.
80. Runyon BA. Treatment of patients with cirrhosis and ascites. Semin Liver Dis 1997; 17: 249-60.
81. Rasmussen HH, Kondrup J, Staun M et al. A method for implementation of nutritional therapy in hospitals. Clin Nutr 2006; 25: 515-23.
82. Merli M, Nicolini G, Angeloni S, Riggio O. Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition 2002; 18: 978-86.